Views & Analysis Listening to the Patient Voice: Collaborate to meet unmet in... Pharma has a real willingness to listen to the patient voice – but how best can we turn that desire into action?
Views & Analysis Improving health literacy is in pharma’s interests Patients who understands the information provided about their health are more likely to adhere to a medicine regime and feel empowered to take steps towards healthier lifestyles. To what extent are pharma companies taking the initiative?
Views & Analysis Pharma websites: a great time to get closer to patients Wary US consumers present opportunities for pharma to become trusted resources for health information.
Views & Analysis Clinical trial summaries for lay people – unpicking the guid... Creating drug trial summaries that the public can understand.
Views & Analysis Health literacy: help pharma communicate with patients Health literacy study suggests more than 90% of adults need health information to be written for a reading age of 9-11 years.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.